Harrington-Smith Kristen
Insider CIK 1894310 · EFTR Director · IMGN SVP & Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-06-13 | 2024-06-13 | 800 | — | $0 | 800 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-02-19 | 2024-02-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-06-22 | 2023-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-01-20 | 2023-01-24 | 28,125 | — | $0 | 28,125 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2022-11-15 | 2022-11-18 | 25,000 | — | $0 | 50,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2022-11-15 | 2022-11-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-06-09 | 2022-06-13 | 13,333 | — | $0 | 13,333 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-11-15 | 2021-11-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-11-15 | 2021-11-17 | 450,000 | $5.68 | $2.56M | 450,000 | SEC↗ |